financetom
Business
financetom
/
Business
/
OpenAI unveils new AI model as competition heats up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI unveils new AI model as competition heats up
May 13, 2024 5:25 PM

(Reuters) - ChatGPT maker OpenAI said on Monday it would release a new AI model called GPT-4o, capable of realistic voice conversation and able to interact across text and image, its latest move to stay ahead in a race to dominate the emerging technology.

New audio capabilities enable users to speak to ChatGPT and obtain real-time responses with no delay, as well as interrupt ChatGPT while it is speaking, both hallmarks of realistic conversations that AI voice assistants have found challenging, the OpenAI researchers showed at a livestream event.

"It feels like AI from the movies ... Talking to a computer has never felt really natural for me; now it does," OpenAI CEO Sam Altman wrote in a blog post.

Microsoft ( MSFT )-backed OpenAI faces growing competition and pressure to expand the user base of ChatGPT, its popular chatbot product that wowed the world with its ability to produce human-like written content and top-notch software code. 

At the livestream event, OpenAI researchers showed off ChatGPT's new voice assistant capabilities. In one demo, ChatGPT used its vision and voice capabilities to talk a researcher through solving a math equation on a sheet of paper.

In another demo, researchers showed the GPT-4o model's capability of real-time language translation.

OpenAI's demonstrations verged on science-fiction, with ChatGPT and its interlocutor at one point engaging in coquettish banter. The OpenAI researcher told the chatbot he was in a great mood because he was demonstrating "how useful and amazing you are."

ChatGPT responded: "Oh stop it! You're making me blush!"

Altman posted on X after the demo, "her," in what appeared to be a reference to the so named 2013 film by Spike Jonze about a man falling in love with his AI assistant, voiced by Scarlett Johansson.

OpenAI's chief technology officer, Mira Murati, said at the event that the new model would be offered for free because it is more cost-effective than the company's previous models. Paid users of GPT-4o will have greater capacity limits than the company's free users, she said. The GPT-4o model will be available in ChatGPT over the next few weeks, the company said.

Shortly after launching in late 2022, ChatGPT was called the fastest application ever to reach 100 million monthly active users. However, worldwide traffic to ChatGPT's website has been on a roller-coaster ride in the past year and is only now returning to its May 2023 peak, according to analytics firm Similarweb.

OpenAI made the announcements a day before Alphabet is scheduled to hold its annual Google developers' conference, where it is expected to show off its own new AI-related features. Reuters reported last week that OpenAI planned to announce an AI-powered search product, citing sources. But the company decided to delay the search product announcement, according to one source familiar with the matter. 

Shares of Alphabet were down 0.4% on Monday afternoon, after falling nearly 3% earlier in the day. Microsoft ( MSFT ) shares were down 0.2%.

(This story has been refiled to correct the spelling of director Spike Jonze's name in paragraph 9)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
May 30, 2024
09:07 AM EDT, 05/30/2024 (MT Newswires) -- Willow Biosciences ( CANSF ) , a biotechnology company, said Thursday that it signed a multi-product development and licensing partnership with Laurus Labs, a research-driven pharmaceutical and biotechnology company. Under the partnership, Willow will deliver biobased processes for high-value Active Pharmaceutical Ingredients with existing markets, including Willow's BioOxi-based corticosteroid processes, for large-scale manufacturing,...
Jacobs Solutions to Design Phase 2 Expansion of Hamilton, Ontario, Wastewater Plant
Jacobs Solutions to Design Phase 2 Expansion of Hamilton, Ontario, Wastewater Plant
May 30, 2024
08:56 AM EDT, 05/30/2024 (MT Newswires) -- Jacobs Solutions ( J ) said Thursday it has been contracted by the City of Hamilton, Ontario, to provide engineering services for the Woodward Avenue Wastewater Treatment Plant Phase 2 Expansion. The $310 million project, part of the city's Clean Harbour Program, is slated for completion by 2032. The expansion will boost the...
FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma
FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma
May 30, 2024
09:01 AM EDT, 05/30/2024 (MT Newswires) -- Candel Therapeutics ( CADL ) said Thursday that the US Food and Drug Administration has granted orphan drug designation to CAN-3110 to treat recurrent high-grade glioma. The orphan drug designation for CAN-3110 further reinforces the potential of this therapy and underscores the urgent need for novel and effective treatments for patients with rHGG,...
Chorus Aviation's Jazz Unit Invests in Emissions Reduction Initiative
Chorus Aviation's Jazz Unit Invests in Emissions Reduction Initiative
May 30, 2024
09:05 AM EDT, 05/30/2024 (MT Newswires) -- Chorus Aviation Inc. ( CHRRF ) subsidiary Jazz Aviation LP on Thursday announced an agreement with France-based, Expliseat, a manufacturer of ultra-light aircraft seats with a focus on sustainability, durability, and passenger comfort. A statement noted this agreement is part of a $10 million investment in Jazz's Air Canada Express cabin modernization for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved